{"SPADE_UN_09935": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 5616327 A", "Patent Link": "http://www.lens.org/lens/patent/US_5616327_A", "Patent Type": "Granted Patent", "Publication Date": "1997-4-1", "Family Info": "CA2108263A1,DE69223406D1,DE69223406T2,EP0590055A1,EP0590055B1,WO1992022575A1", "Patent Title": "M-protein peptides of influenza virus as antiviral agents.", "Abstract": "Peptides substantially corresponding to the 148-162 region of type A influenza M protein and additionally containing at least one amino acid in the 163-166 region are disclosed to have high activity as influenza transcription inhibitors and thus as antiviral agents against influenza virus and other RNA viruses. The modification of these peptides by incorporation into liposomes or by addition of long-chain alkylamino acids is also shown as in the use of all such materials in antiviral drug formulations."}], "Sequence Information": {"SPADE ID": "SPADE_UN_09935", "Sequence": "CXTCEQIADSQHXSHXQMV", "Sequence Length": 19, "Peptide Name": "Sequence 48 from Patent US 5616327", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "QXC", "Absent Amino Acids": "FGKLNOPRUWY", "Basic Residues": 2, "Acidic Residues": 2, "Hydrophobic Residues": 4, "Polar Residues": 12, "Positive Residues": 2, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00645", "Similarity": 1.0, "Sequence": "REMVKAEVNCIGGKCPEGKKNCNCMPPIAHVMDDIRPCNTDGDCYKFCPRECELGTCYCRCDYGCTCTC"}, {"SPADE_ID": "SPADE_UN_09900", "Similarity": 1.0, "Sequence": "CTCEQIADSQHRSHRQMV"}, {"SPADE_ID": "SPADE_UN_09931", "Similarity": 1.0, "Sequence": "CTCEQIADSQHRSHRQMV"}]}}}